Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Discover the full record of transactions filed by Ms D Waterhouse. Insider active across 1 company, notably GSK plc. Aggregated, 5 filings have been published. History available since 9 June 2023. The latest transaction was filed on 17 July 2023 (Vesting). Regulator: RNS (LSE). All data is openly available.
Companies and markets linked to Ms D Waterhouse
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
18 shares@ £13.7967100.0% of flowLondon Stock Exchange (XLON)ISINISIN GB00BN7SWP63RNS:4799763-7
5 of 5 declarations
About Ms D Waterhouse
Ms D Waterhouse is CEO, ViiV Healthcare at GSK plc (XLON). She has 5 filings in total, and across the sampled recent filings the purchases total EUR 1486, the sales total EUR 0, with a date range from 2023-06-12 to 2023-07-20.